Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury
Abstract Traumatic spinal cord injury (SCI) produces a complex syndrome that is expressed across multiple endpoints ranging from molecular and cellular changes to functional behavioral deficits. Effective therapeutic strategies for CNS injury are therefore likely to manifest multi-factorial effects...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-82951-5 |
| _version_ | 1818424934513246208 |
|---|---|
| author | J. R. Huie A. R. Ferguson N. Kyritsis J. Z. Pan K.-A. Irvine J. L. Nielson P. G. Schupp M. C. Oldham J. C. Gensel A. Lin M. R. Segal R. R. Ratan J. C. Bresnahan M. S. Beattie |
| author_facet | J. R. Huie A. R. Ferguson N. Kyritsis J. Z. Pan K.-A. Irvine J. L. Nielson P. G. Schupp M. C. Oldham J. C. Gensel A. Lin M. R. Segal R. R. Ratan J. C. Bresnahan M. S. Beattie |
| author_sort | J. R. Huie |
| collection | DOAJ |
| description | Abstract Traumatic spinal cord injury (SCI) produces a complex syndrome that is expressed across multiple endpoints ranging from molecular and cellular changes to functional behavioral deficits. Effective therapeutic strategies for CNS injury are therefore likely to manifest multi-factorial effects across a broad range of biological and functional outcome measures. Thus, multivariate analytic approaches are needed to capture the linkage between biological and neurobehavioral outcomes. Injury-induced neuroinflammation (NI) presents a particularly challenging therapeutic target, since NI is involved in both degeneration and repair. Here, we used big-data integration and large-scale analytics to examine a large dataset of preclinical efficacy tests combining five different blinded, fully counter-balanced treatment trials for different acute anti-inflammatory treatments for cervical spinal cord injury in rats. Multi-dimensional discovery, using topological data analysis (TDA) and principal components analysis (PCA) revealed that only one showed consistent multidimensional syndromic benefit: intrathecal application of recombinant soluble TNFα receptor 1 (sTNFR1), which showed an inverse-U dose response efficacy. Using the optimal acute dose, we showed that clinically-relevant 90 min delayed treatment profoundly affected multiple biological indices of NI in the first 48 h after injury, including reduction in pro-inflammatory cytokines and gene expression of a coherent complex of acute inflammatory mediators and receptors. Further, a 90 min delayed bolus dose of sTNFR1 reduced the expression of NI markers in the chronic perilesional spinal cord, and consistently improved neurological function over 6 weeks post SCI. These results provide validation of a novel strategy for precision preclinical drug discovery that is likely to improve translation in the difficult landscape of CNS trauma, and confirm the importance of TNFα signaling as a therapeutic target. |
| first_indexed | 2024-12-14T14:05:56Z |
| format | Article |
| id | doaj.art-e3769cfbde174ac4a0a3ca905c1c4a7c |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-14T14:05:56Z |
| publishDate | 2021-02-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-e3769cfbde174ac4a0a3ca905c1c4a7c2022-12-21T22:58:33ZengNature PortfolioScientific Reports2045-23222021-02-0111111110.1038/s41598-021-82951-5Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injuryJ. R. Huie0A. R. Ferguson1N. Kyritsis2J. Z. Pan3K.-A. Irvine4J. L. Nielson5P. G. Schupp6M. C. Oldham7J. C. Gensel8A. Lin9M. R. Segal10R. R. Ratan11J. C. Bresnahan12M. S. Beattie13Department of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaDepartment of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaDepartment of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaDepartment of Anesthesiology, University of California San FranciscoDepartment of Anesthesiology, Veterans Affairs Palo Alto Health Care SystemDepartment of Psychiatry and Behavioral Sciences, University of MinnesotaBrain Tumor Research Center, University of CaliforniaBrain Tumor Research Center, University of CaliforniaSCoBIRC, University of KentuckyDepartment of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaDepartment of Epidemiology and Biostatistics, Center for Bioinformatics and Molecular Biostatistics, University of California San FranciscoDepartment of Neurology and Neuroscience, Burke-Cornell Medical Research Institute, Weill Medical College of Cornell UniversityDepartment of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaDepartment of Neurological Surgery, Brain and Spinal Injury Center (BASIC), University of CaliforniaAbstract Traumatic spinal cord injury (SCI) produces a complex syndrome that is expressed across multiple endpoints ranging from molecular and cellular changes to functional behavioral deficits. Effective therapeutic strategies for CNS injury are therefore likely to manifest multi-factorial effects across a broad range of biological and functional outcome measures. Thus, multivariate analytic approaches are needed to capture the linkage between biological and neurobehavioral outcomes. Injury-induced neuroinflammation (NI) presents a particularly challenging therapeutic target, since NI is involved in both degeneration and repair. Here, we used big-data integration and large-scale analytics to examine a large dataset of preclinical efficacy tests combining five different blinded, fully counter-balanced treatment trials for different acute anti-inflammatory treatments for cervical spinal cord injury in rats. Multi-dimensional discovery, using topological data analysis (TDA) and principal components analysis (PCA) revealed that only one showed consistent multidimensional syndromic benefit: intrathecal application of recombinant soluble TNFα receptor 1 (sTNFR1), which showed an inverse-U dose response efficacy. Using the optimal acute dose, we showed that clinically-relevant 90 min delayed treatment profoundly affected multiple biological indices of NI in the first 48 h after injury, including reduction in pro-inflammatory cytokines and gene expression of a coherent complex of acute inflammatory mediators and receptors. Further, a 90 min delayed bolus dose of sTNFR1 reduced the expression of NI markers in the chronic perilesional spinal cord, and consistently improved neurological function over 6 weeks post SCI. These results provide validation of a novel strategy for precision preclinical drug discovery that is likely to improve translation in the difficult landscape of CNS trauma, and confirm the importance of TNFα signaling as a therapeutic target.https://doi.org/10.1038/s41598-021-82951-5 |
| spellingShingle | J. R. Huie A. R. Ferguson N. Kyritsis J. Z. Pan K.-A. Irvine J. L. Nielson P. G. Schupp M. C. Oldham J. C. Gensel A. Lin M. R. Segal R. R. Ratan J. C. Bresnahan M. S. Beattie Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury Scientific Reports |
| title | Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury |
| title_full | Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury |
| title_fullStr | Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury |
| title_full_unstemmed | Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury |
| title_short | Machine intelligence identifies soluble TNFa as a therapeutic target for spinal cord injury |
| title_sort | machine intelligence identifies soluble tnfa as a therapeutic target for spinal cord injury |
| url | https://doi.org/10.1038/s41598-021-82951-5 |
| work_keys_str_mv | AT jrhuie machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT arferguson machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT nkyritsis machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT jzpan machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT kairvine machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT jlnielson machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT pgschupp machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT mcoldham machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT jcgensel machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT alin machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT mrsegal machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT rrratan machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT jcbresnahan machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury AT msbeattie machineintelligenceidentifiessolubletnfaasatherapeutictargetforspinalcordinjury |